A phase I clinical study of naked DNA ex
✍
Yongquan Gu; Jian Zhang; Lianrui Guo; Shijun Cui; Xuefeng Li; Dayou Ding; Jong-M
📂
Article
📅
2011
🏛
John Wiley and Sons
🌐
English
⚖ 254 KB
## Abstract ## Background The purpose of the present phase I clinical trial was to evaluate the safety, tolerability, and preliminary efficacy of naked DNA therapy expressing two isoforms of hepatocyte growth factor (pCK‐HGF‐X7) in critical limb ischemia (CLI) patients. ## Materials and methods